Clinical trials are an important way to improve treatment for people with cancer. While most are continuing during the COVID-19 pandemic, the period of time that clinical trials are available and recruiting may change quickly. If you would like to get involved in a clinical trial, speak to your treatment team or the health service where the clinical trial is being undertaken, to confirm it is open and appropriate for you. For cancer information and support, call Cancer Council's experienced cancer nurses on 13 11 20 Monday to Friday from 9am-5pm.

RoLaCaRT-1 : An international randomised phase II trial comparing surgical outcomes of robotic-assisted right hemicolectomy versus laparoscopic-assisted hemicolectomy for resection of adenocarcinoma of the caecum, ascending or proximal transverse colon

Male or<br/>FemaleGender Male or
Female

RecruitingStatus Recruiting

Surgical<br/>TrialTypeSurgical
Trial

TwoPhase Two

18+Age Over 18

Bowel<br/>CancersCancer LocationBowel
Cancers

Surgical | Bowel (colorectum)Colon,Colorectum,Rectum

Trial Overview Read MoreRead more

The aim of this trial is to compare the use of robotic surgery with laparoscopic ('keyhole') surgery for the treatment of right sided colon cancer.
 

This trial is treating patients with colon cancer.

This is a surgical trial.

You may be able to join this trial if:

  • Your cancer has not spread to other parts of the body.

You may be excluded from this trial if:

  • You have a certain disease or psychological condition.
  • You have been diagnosed with a prior or secondary type of cancer.

Clinical trials have complex eligibility criteria - talk to your doctor about your interest in this trial.

Clinical Summary Read MoreRead more

Trial Identifiers

Use the hyperlinks, where available to access additional clinical trial information.

Scientific Title

An international randomised phase II trial comparing surgical outcomes of robotic-assisted right hemicolectomy versus laparoscopic-assisted hemicolectomy for resection of adenocarcinoma of the caecum, ascending or proximal transverse colon

Cooperative Group

Australasian Gastro-Intestinal Trials Group (AGITG)

Commercial Sponsor

Intuitive Inc.

Summary

Participants will be randomly allocated to receive either robotic or laparoscopic surgery for the surgical treatment of their cancer. There will be a two in one chance that patients are allocated to receive robotic surgery. This study will evaluate the short and longer term outcomes, quality of life, cost effectiveness and surgeons’ experience with the robotic surgery approach.

Recruiting Hospitals Read MoreRead more

Peter MacCallum Cancer Centre, Surgery
Parkville
Ms Joanne Benhamu
SurgicalResearchteam@petermac.org
03 8559 5000

Trial Overview: General information about a clinical trial. This section provides an overview of who might be able to join this trial and what type of treatment is involved.

Next